National Pension Service boosted its stake in CVS Health Corp (NYSE:CVS) by 36.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,261,873 shares of the pharmacy operator’s stock after buying an additional 335,312 shares during the quarter. National Pension Service owned approximately 0.12% of CVS Health worth $85,416,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of CVS. Bell Rock Capital LLC lifted its stake in CVS Health by 764.0% in the 4th quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 382 shares in the last quarter. Daiwa SB Investments Ltd. purchased a new position in CVS Health in the 4th quarter worth approximately $30,000. Acima Private Wealth LLC purchased a new position in CVS Health in the 4th quarter worth approximately $33,000. Murphy Pohlad Asset Management LLC purchased a new position in CVS Health in the 4th quarter worth approximately $39,000. Finally, Cornerstone Advisors Inc. lifted its stake in CVS Health by 71.6% in the 3rd quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock worth $40,000 after purchasing an additional 212 shares in the last quarter. 81.55% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Larry J. Merlo sold 166,368 shares of CVS Health stock in a transaction that occurred on Friday, February 1st. The shares were sold at an average price of $64.51, for a total value of $10,732,399.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director C David Brown II bought 10,000 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was bought at an average price of $53.18 per share, with a total value of $531,800.00. Following the acquisition, the director now directly owns 16,222 shares in the company, valued at approximately $862,685.96. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 23,600 shares of company stock valued at $1,270,896 and have sold 245,671 shares valued at $15,839,966. 0.53% of the stock is owned by company insiders.
CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.07. The business had revenue of $54.42 billion during the quarter, compared to the consensus estimate of $53.78 billion. CVS Health had a negative net margin of 0.31% and a positive return on equity of 17.49%. The business’s revenue was up 12.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.92 EPS. On average, sell-side analysts expect that CVS Health Corp will post 6.79 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Tuesday, April 23rd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.80%. CVS Health’s dividend payout ratio is currently 28.25%.
A number of research analysts have weighed in on the stock. CIBC reissued a “market perform” rating on shares of CVS Health in a research note on Monday, April 15th. Raymond James decreased their target price on shares of CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research note on Thursday. SunTrust Banks decreased their target price on shares of CVS Health from $85.00 to $65.00 in a research note on Wednesday, April 10th. BMO Capital Markets assumed coverage on shares of CVS Health in a research note on Wednesday, April 10th. They issued an “outperform” rating and a $58.00 target price on the stock. Finally, Guggenheim assumed coverage on shares of CVS Health in a research note on Thursday. They issued a “buy” rating and a $75.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $79.15.
WARNING: This article was first published by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/cvs-health-corp-cvs-stake-raised-by-national-pension-service.html.
CVS Health Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Recommended Story: Penny Stocks
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.